ATF4 and type 2 diabetes mellitus: Among the 3 arms of the UPR, we demonstrated that elevated ATF4 activity in T2D β-cells suppressed the cAMP signaling of incretin receptors through transcriptional activation of cAMP-degrading PDE4D (Lee et al., 2023).